Patients with ESRD may now have a tool to help them decide on kidney transplantation.
Researcher points out what he considers important flaws and limitations of three studies.
Greater efforts may be needed to educate patients with end-stage renal disease, especially African Americans.
The trend is most pronounced among Medicare recipients since the debut of bundling, ESA labeling changes.
Risk of recurrent bleeding is similar to that of patients with normal kidney function.
A new link has been found between atrial fibrillation and end-stage renal disease among patients with chronic kidney disease.
Researchers made the discovery in a study of individuals with normal kidney function.
Patients have a 30% decreased risk of all-cause mortality and a 55% decreased risk of infection-related death.
NDT for selected patients with ESRD, is used much more frequently in the U.K. and Europe than in the U.S.
Conservative approach can improve the quality of life in patients with extensive comorbidities.
No anti-HLA antibodies developed following administration of the influenza A/H1N1 vaccine.
The condition was found in nearly 32% of hemodialysis patients, compared with only 8% and 5% of peritoneal dialysis and kidney transplant patients.
No increase found in the risk of advanced CKD or ESRD with prolonged use of antiretrovirals previously found to be associated with moderate levels of CKD.
Ultrasound can identify asymptomatic congestion and better inform risk in dialysis patients
Some individual components of the syndrome also found to increase risk.
Likelihood of end-stage renal disease is increased 14-fold among women with hypertensive disorders in pregnancy.
Intensive blood glucose control can improve renal outcomes in patients with type 2 diabetes, including a significant reduction in the likelihood of progressing to ESRD.
The top reason: end-stage renal disease patients are too complicated.
The incidence of AKI requiring dialysis is now higher than the incidence of ESRD requiring dialysis or transplant.
Hemodialysis and peritoneal dialysis patient experience similar amelioration in glomerular filtration rate decline.
Scientific speculation suggests that uremic toxins, viral mediators, and immune inhibition could play a role in malignant transformation.
Genetic changes may partly explain why African-Americans with lupus are up to five times more likely develop end-stage kidney disease.
End-stage renal disease is three times and nearly seven times more likely to occur in overweight and obese adolescents, respectively.
Metabolic syndrome (MetS) in patients with stage 3 and 4 CKD is associated with an increased risk of development of ESRD.
The Kidney Health Initiative aims to advance scientific understanding of the patient safety and treatment implications of new and existing medical products.
Among middle-aged individuals, men have a 2.6% risk of developing end-stage renal disease during their lives compared with 1.76% risk for women.
In recent trips to India, China, Brazil, and other countries, I was intrigued by large numbers of patients with end-stage renal disease who underwent hemodialysis (HD) less frequently than three times a week.
Silymarin significantly decreased UACR compared with placebo in patients with diabetic nephropathy.
Renal transplant recipients have better cancer-specific survival than dialysis patients.
Payment rates are expected to rise by 2.5% in 2013.